“If they had the power to do to us what we are able to do to them, not one of us would live for an hour. But since they lack the power to do this publicly, they remain our daily murderers and bloodthirsty foes in their hearts.” – Martin Luther (1483-1546): On The Jews and Their Lies: 9/11, p. 141
April 5, 2020
A new study published in the journal Antiviral Research finds that Ivermectin, a common agricultural drug used as a de-wormer for cats, dogs, horses and livestock — achieves a 5000-fold reduction in replication of the SARS-cov-2 “Wuhan” coronavirus.
Ivermectin is sold at agricultural supply stores and online retailers such as Amazon.com. It’s normally sold as an edible paste or a sterile solution for injection into cattle and other livestock. The drug is FDA-approved for certain treatments, although not yet FDA approved for treatment of COVID-19. We are not recommending it for human consumption until more data are available.
The study, found here, is entitled, “The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro.”
The abstract of the study describes the very strong potential of Ivermectin to inhibit viral replication in vitro. This was not a human clinical trial, of course, but the results make Ivermectin an immediate candidate for further study:
We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM cells 2 hours post infection with SARS-CoV-2 able to effect ?5000-fold reduction in viral RNA at 48 h. Ivermectin therefore warrants further investigation for possible benefits in humans.
Ivermectin is well known to exhibit strong anti-viral properties and is even documented to inhibit HIV replication. This is important to note, since the Wuhan coronavirus, an engineered biological weapon, uses HIV components as part of its infection and replication machinery. As described in the abstract:
Ivermectin is an FDA-approved broad spectrum anti-parasitic agent that in recent years we, along with other groups, have shown to have anti-viral activity against a broad range of viruses in vitro. Originally identified as an inhibitor of interaction between the human immunodeficiency virus-1 (HIV-1) integrase protein (IN) and the importin (IMP) ?/?1 heterodimer responsible for IN nuclear import, Ivermectin has since been confirmed to inhibit IN nuclear import and HIV-1 replication.
Join The Fight Today!
Camelot Daily is one of a few independent news agencies willing to expose the ‘synagogue of Satan’s (S.O.S.) assault on civilization. More people than ever are receiving our message. However, S.O.S. controlled monopolies such as Google, Facebook, Twitter etc. “96% of the World’s Media,” have eviscerated our advertising revenues, using government subsidized unconstitutional, Maoist like, schizophrenic censorship. It’s noteworthy to mention that Israeli scientists discovered 99.9% of Ashkenazi Jews have a 40% chance of developing schizophrenia, certainly not the type of people you want creating policies that effect the whole world and yet social media giant Facebook, 800lb search engine gorilla Google and the web’s most ubiquitous discussion network Disqus are all controlled by individuals who may be schizophrenic. The Camelot team, humbly ask our readers from around the world to support us by sharing our articles, supporting our advertisers, purchasing one of our liberty themed t-shirts at: TreasonTees.com and by donating to Camelot at PayPal.Me/silvanusmedia or to donate bitcoin, copy and paste the following Bitcoin Wallet Address: mqGTT5X4BrVTdhbhxX93ojcaumSSXXFHSr Thank You!
Camelot Daily’s independent, S.O.S. exposing news journalism requires a great deal of time and money. However, we care about those who are awake and opposed to the S.O.S.’s goal of exterminating all human life on earth. If everyone who reads and likes our reporting, help us, Camelot Daily will become more effective at defeating the S.O.S. For as little as $5, you can support Camelot – and it only takes a minute. Thank you.